LSS #4: How to optimise your regulatory exclusivity rights for pharmaceutical products?

Our experts, Kirian Claeyé and Laura Traest, will be focusing on regulatory exclusivity rights for pharmaceutical products, which will include data exclusivity, orphan exclusivity, SPCs and paediatric rewards. They will navigate the maze of regulatory exclusivity rights, update you on a number of significant recent developments, and discuss what is still to come.
Specific topics will include:

The SPC manufacturing waiver
The CJEU’s latest case-law on SPC rights: Santen and Royalty Pharma
The European Commission’s review of Orphan Exclusivity and Paediatric Extensions
The General Court’s very recent Polpharma ruling on Data Exclusivity